Fundraising FoxNew Vital Signs
Ann Arbor, US · Founded 2015 · Delaware corporation
Find your way into New Vital Signs
Each arrow is one introduction. Sign up to fill in the first one.
Ask Bob Stefanski to introduce you to Doug Neal
You →Bob · together at eLab Ventures →Doug
Sign up to find every way you can get introduced to New Vital Signs
- Your email: who you already know at New Vital Signs, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the New Vital Signs team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
New Vital Signs is developing a wearable monitoring platform that measures a new generation of precision vital signs to detect physiologic changes earlier than traditional monitors, aimed at identifying at-risk patients (e.g. sepsis, trauma, heart failure, traumatic brain injury). Its products include DRIVE (respiratory/circulating volume), TOBI (cerebral autoregulation), and VATMOS (peripheral vascular tone), developed in partnership with the University of Michigan Center for Integrative Research in Critical Care.</parameter> <parameter name="founders">[]
Founders & leadership
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2016
▶$1MraisedSep 2016 · 1 investors · BiotechnologyRule 506(b)
- Doug NealExecutive Officer, Director
- Kevin WardDirector
- Dominic SpadaforeExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does New Vital Signs do?
- New Vital Signs is developing a wearable monitoring platform that measures a new generation of precision vital signs to detect physiologic changes earlier than traditional monitors, aimed at identifying at-risk patients (e.g. sepsis, trauma, heart failure, traumatic brain injury). Its products include DRIVE (respiratory/circulating volume), TOBI (cerebral autoregulation), and VATMOS (peripheral vascular tone), developed in partnership with the University of Michigan Center for Integrative Research in Critical Care.</parameter> <parameter name="founders">[]
- How much funding has New Vital Signs raised?
- New Vital Signs has disclosed $1M raised across 1 round.
- Where is New Vital Signs headquartered?
- New Vital Signs is headquartered in Ann Arbor, US.